Везде
Standardization and personalized medicine phenomenon
Table of contents
Annotation Estimate Publication content
References Comments
Share
QR
Metrics
Standardization and personalized medicine phenomenon
Annotation
PII
S0236-20070000616-8-1
Publication type
Article
Status
Published
Authors
Sergei Y. Shevchenko 
Edition
Issue 6
Pages
118-128
Abstract
Interrelation of individualization and standardization can be revealed in personalized medicine. Interdependence of these processes creates a space for construction of a new nosologi-cal classification, a new concept of disease as well as for elaboration of a new presentation of Human biological individuality.
Keywords
PERSONALIZED MEDICINE, CONSTRUCTIVISM, INDIVIDUALIZATION/STANDARDIZATION, BIOPOWER
Date of publication
01.12.2015
Number of purchasers
1
Views
990
Readers community rating
0.0 (0 votes)
Cite Download pdf
1

References



Additional sources and materials

    

  1. Bek U. Obschestvo riska. Na puti k drugomu modernu. M.: Progress-Traditsiya, 2000. S. 192.
    2. 

  2. Belyaletdinov R.R., Grebenschikova E.G., Kiyaschenko L.P., Popova O.V., Tischenko P.D., Yudin B.G.Sotsiogumanitarnoe obespechenie proektov personalizirovannoj meditsiny: filosofskij aspekt // Znanie. Ponimanie. Umenie. 2014. № 4. S. 12-26.
    3. 

  3. Lo D. Posle metoda: besporyadok i sotsial'naya nauka. M.: Izd-vo Instituta Gajdara, 2015. S. 326.
    4. 

  4. Prakticheskie rekomendatsii po lekarstvennomu lecheniyu zlokachestvennykh opukholej / Pod red. V.M. Moiseenko. M. 2014. S. 95.
    5. 

  5. Rozin V.M. Opyt gumanitarnogo izucheniya tvorchestva (Ehvolyutsiya vzglyadov M. Fuko) // Obschestvennye nauki i sovremennost'. 2000. № 3. S. 133.
    6. 

  6. Tischenko P.D. Vremya i ontologiya "Da Budet! (Fiat!)". URL: http://vox-journal.org/html/issues/vox1/4 (data obrascheniya: 21.04.2015).
    7. 

  7. Fuko M. Volya k znaniyu // Fuko M. Volya k istine. M.: Kastal', 1996. S. 145.
    8. 

  8. Fuko M. Rozhdenie biopolitiki. M.: Nauka, 2010. S. 48.
    9. 

  9. Yudin B.G. Tochka zreniya iskusstvennogo // Gumanitarnye orientiry nauchnogo poznaniya. M., 2014. C. 23.
    10. 

  10. Boenink M. Molecular medicine and concepts of disease: the ethical value of a conceptual analysis of emerging biomedical technologies // Medicine, Health Care and Philosophy. 2010. № 13 (1). P. 11-23.
    11. 

  11. Dekkers W., Rikkert M.O. What is a genetic cause? The example of Alzheimer's Disease // Medicine, Health Care and Philosophy. 2006. Vol. 9. Issue 3. P. 273-284.
    12. 

  12. Demidova I., Tzepenschikova E., Imyanitov E.N., Tjulandin S. ALK rearrangements in non-small cell lung cancer Russian patients // Annals of Oncology. 2014. Vol. 25 (Supplement 4). URL: http://annonc.oxfordjournals.org/content/25/ suppl_4/iv460.2.full.pdf html?sid=0fd8b031-1a1f-4588-9fda-f35106ab0e32 (data obrascheniya: 27.04.2015).
    13. 

  13. Denford S, Frost J, Dieppe P. Individualisation of drug treatments for patients with long-term conditions: a review of concepts // BMJ Open. 2014. URL: http://bmjopen.bmj.com/content/4/3/e004172.abstract (data obrascheniya: 11.05.2015).
    14. 

  14. Epstein S. Inclusion: the politics of difference in medical research. Chicago; London, 2007. P. 138-141.
    15. 

  15. Lass W.G. et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection // J. Exp. Med. 2006. № 1. P. 35-40.
    16. 

  16. Haraway D. Simians, Cyborgs, and Women: The Reinvention of Nature. 1991. P. 185.
    17. 

  17. Hunt KKModern breast cancer staging should include tumor biology. URL: http://www.cancernetwork.com/mbcc-2015/modern-breast-cancer-stag-ing-should-include-tumor-biology (data obrascheniya: 24.04.2015).
    18. 

  18. Imyanitov E.N., Demidova I., Kikeeva T., Gordiev M. et al. Organization of nationwide EGFR testing in Russia: first experience // Annals of Oncology. 2014. Vol. 25 (Supplement 4). URL: http://annonc.oxfordjournals.org/content/25/ suppl_4/iv561.2.full.pdf html?sid=0fd8b031-1a1f-4588-9fda-f35106ab0e32 (data obrascheniya: 27.04.2015).
    19. 

  19. Iqbal J., Ginsburg O. et. al. Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States // JAMA. 2015. Vol. 313 (2). P. 165-173. URL: http:// href='contents.asp?titleid=6595' title='JAMA'>JAMA.JAMAnetwork.com/ article.aspx?articleid=2089353 (data obrascheniya: 29.04.2015).
    20. 

  20. Jack C.R., Knopman D.S. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade // Lancet Neurol. 2010. Jan. Vol. 9 (1). P. 119.
    21. 

  21. Mazjwes J., Peters S., Lepage B. Lung cancer that harbors a HER2 mutation: Epidemiologic Characteristics and Therapeutic Perspectives // J. Clin. Oncol. URL: http://jco.ascopubs.org/content/31/16/1997.full.pdf (data obrascheniya: 5.05.2015).
    22. 

  22. Rui Chen et al. Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes // Cell. 2012. Vol. 148. Issue 6. P. 1293-1307.
    23. 

  23. Sabeti P.C. et al. The case for selection at CCR5-Delta32 // PLoS Biology. 2005. № 11. P. 378.
    24. 

  24. Schleidgen S. What is personalized medicine: sharpening a vague term based on a systematic literature review // BMC Medical Ethics. 2013. URL: http://www.biomedcentral.com/1472-6939/14/55 (data obrascheniya: 11.05.2015).
    25. 

  25. Tutton R. Genomics and the Reimagining of Personalized Medicine. Ashgate, 2014. P. 19-41.
    26.

Comments

No posts found

Write a review
Translate